Hemogenyx Pharmaceuticals (HEMO) Stock Chart & Stock Price History GBX 172.50 +1.50 (+0.88%) As of 04/17/2025 11:50 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesBuy This Stock Hemogenyx Pharmaceuticals Stock Price Performance 5 Day Performance+0.88%1 Month Performance-4.96%3 Month Performance-53.75%6 Month Performance+12,363.87%Year-To-Date Performance-57.09%1 Year Performance+10,411.88% Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address HEMO Stock Chart for Monday, April, 21, 2025 HEMO Chart by TradingView Hemogenyx Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2025GBX 172.50GBX 172.50GBX 172.50GBX 165.5041,412 shs£6.15 million04/17/2025GBX 171GBX 172.50+0.88%GBX 172.50GBX 165.5041,412 shs£6.15 million04/16/2025GBX 170.50GBX 171+0.29%GBX 171GBX 165.7523,526 shs£6.10 million04/15/2025GBX 168.70GBX 170.50+1.07%GBX 170.50GBX 16511,464 shs£6.08 million04/14/2025GBX 168.50GBX 168.70+0.12%GBX 173.22GBX 168.2015,254 shs£6.01 million04/11/2025GBX 171.75GBX 168.50-1.89%GBX 173.85GBX 165.5038,767 shs£6.01 million04/10/2025GBX 167.25GBX 171.75+2.69%GBX 173.75GBX 16717,117 shs£6.12 million04/09/2025GBX 172.75GBX 167.25-3.18%GBX 167.25GBX 16524,101 shs£5.96 million04/09/2025GBX 172.75GBX 167.25-3.18%GBX 167.25GBX 16524,101 shs£5.96 million04/08/2025GBX 174.50GBX 172.75-1.00%GBX 174.50GBX 165.5020,310 shs£6.16 million Get the Latest News and Ratings for HEMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/08/2025GBX 174.50GBX 172.75-1.00%GBX 174.50GBX 165.5020,310 shs£6.16 million04/07/2025GBX 181.98GBX 174.50-4.11%GBX 180.25GBX 165.5034,777 shs£6.22 million04/04/2025GBX 189GBX 181.98-3.72%GBX 190GBX 181.9810,123 shs£6.49 million04/03/2025GBX 194.36GBX 189-2.76%GBX 195GBX 1892,507 shs£6.74 million04/02/2025GBX 198GBX 194.36-1.84%GBX 197.50GBX 18918,840 shs£6.93 million04/01/2025GBX 196.09GBX 198+0.98%GBX 198GBX 1895,258 shs£7.06 million03/31/2025GBX 197.50GBX 196.09-0.72%GBX 198GBX 189.5012,591 shs£6.99 million03/28/2025GBX 193.80GBX 197.50+1.91%GBX 197.50GBX 182.5014,733 shs£7.04 million03/27/2025GBX 195.28GBX 193.80-0.76%GBX 198GBX 1864,801 shs£6.91 million03/26/2025GBX 189.49GBX 195.28+3.05%GBX 195.28GBX 185.5015,502 shs£6.96 million03/25/2025GBX 190GBX 189.49-0.27%GBX 195GBX 182.9831,793 shs£6.75 million03/24/2025GBX 181.50GBX 190+4.68%GBX 192GBX 180.5030,924 shs£6.77 million03/21/2025GBX 177.63GBX 181.50+2.18%GBX 190GBX 175.98152,277 shs£6.47 million03/20/2025GBX 169.16GBX 177.63+5.01%GBX 177.63GBX 168.5013,487 shs£6.33 million Related Companies Sareum Stock Price Chart OptiBiotix Health Stock Price Chart Arecor Therapeutics Stock Price Chart Poolbeg Pharma Stock Price Chart ImmuPharma Stock Price Chart Synairgen Stock Price Chart Oxford BioDynamics Stock Price Chart IXICO Stock Price Chart Fusion Antibodies Stock Price Chart Cizzle Biotechnology Stock Price Chart Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:HEMO) was last updated on 4/21/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemogenyx Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemogenyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HEMO Stock Free HEMO Stock Alerts